The Bulletin
The Times


.

Medera Announces Completion of Cohort A and Initiation of Dosing in Cohort B of MUSIC-HFpEF, a Phase 1/2a Clinical Trial Evaluating First-In-Human Gene Therapy SRD-002 for Heart Failure with Preserved Ejection Fraction

  • Written by PR Newswire
  • Heart failure is a global pandemic with an estimated 64.3 million cases worldwide, costing over US$100B per year
  • Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure cases, but has limited disease-modifying therapeutics
  • Promising efficacy results in cardiovascular performance observed in Cohort A...
hacklink hack forum hacklink film izle hacklink grandpashabetgrandpashabetz library frDeneme bonusu veren siteler 2026Deneme bonusu veren siteler 2026Romabetjojobet girişjojobetjojobetjojobetmarsbahisjojobetprimebahismeritbetbetasus girişjojobetjojobetjojobetjojobetjojobetgrandpashabetgrandpashabetjojobetgrandpashabetcasibom